Several disease-specific factors: tumor stage, tumor grade, prostate-specific antigen (PSA) level; and patient-specific factors: age, co-morbidity and functional status need to be considered in the decision-making process for the diagnosis and management of prostate cancer. The gene discussed is KLK3; the disease is Familial prostate cancer.